Download Full Text (550 KB)
Mobilizing Computable Biomedical Knowledge (MCBK) 2021 Conference
Abstract or Description
The use of de-identified EHR data for clinical and translational research has increased significantly since the HIPAA Privacy Rule De-Identification standards went into effect -Inclusion of SDOH measures in de-identified research is increasing as well, which presents an inherent risk of re-identifying PHI (primarily location units smaller than the state) -Data warehouse architecture and institutional policies need to recognize the risk associated with providing multiple location-based indices -Research interests are secondary to privacy concerns throughout biomedical research, but particularly in de-identified research, which is intended to promote more secure access to EHR data while allowing for expedient access (fewer institutional barriers to entry)
Anzalone, Alfred J.; Geary, Carol Reynolds; and McClay, James C., "Beyond Safe Harbor: Risk of Exposing Location in De-Identified Clinical Data" (2021). Posters and Presentations: Neurological Sciences. 1.